As shown in Figure 4B and 4C, 4T1.2/HER2 tumor-bearing mice showed CTL lytic activity in response to HER263–71 peptides but not to HER2342–350, while CT26/HER2 tumor-bearing mice displayed no such activity. Here, DDX53 is linked to neoplasm.